<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Latent Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is strongly associated with B-cell proliferative diseases such as Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Here we show that the oncogenic serine/threonine kinases Pim-1 and Pim-2 enhance the activity of the <z:mp ids='MP_0001799'>viral</z:mp> transcriptional activator EBNA2 </plain></SENT>
<SENT sid="2" pm="."><plain>During <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> of primary B-lymphocytes, the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels of pim genes, especially of pim-2, are upregulated and remain elevated in latently infected B-cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, EBV-induced upregulation of Pim kinases and Pim-stimulated EBNA2 transcriptional activity may contribute to the ability of EBV to immortalize B-cells and predispose them to malignant growth </plain></SENT>
</text></document>